Identification of Biomarkers, New Treatments, and Vaccines for COVID-19

1. Front Matter

   Pages i-ix

   PDF

2. Background

   1. Front Matter

      Pages 1-1

      PDF

   2. Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement

      • Zari Naderi Ghale-Noie, Arash Salmaninejad, Robert Bergquist, Samaneh Mollazadeh, Benyamin Hoseini, Amirhossein Sahebkar

      Pages 3-22

      PDF

3. Epidemiology

   1. Front Matter

      Pages 23-23

      PDF

   2. Prevalence of COVID-19 and the Continued Citizen-Based Control in Japan

      • Sumino Yanase, Hiroki Sugimori

      Pages 25-33

      PDF

   3. COVID-19 Pandemic in Brazil: History, Characteristics, and Evolution

      • Tamires Duarte Afonso Serdan, Yuanji Tang, Tiago Bertola Lobato, Flaviano Luis Rocha da Silva, Sherry Tang, Laureane Nunes Masi et al.

      Pages 35-47

      PDF

   4. The Experiences of Recovered COVID-19 Patients in Baqiyatallah Hospital: A Qualitative Study

      • Leila Karimi, Somayeh Makvandi, Farshid Rahimi-Bashar, Amir Vahedian-Azimi, Amirhossein Sahebkar

      Pages 49-59

      PDF

4. Risk Factors and Outcomes

   1. Front Matter

      Pages 61-61

      PDF

   2. Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons

      • Amir Tajbakhsh, Khojaste Rahimi Jaberi, Seyed Mohammad Gheibi Hayat, Mehrdad Sharifi, Thomas P. Johnston, Paul C. Guest et al.

      Pages 63-78

      PDF

   3. Sex Differences and COVID-19

      • Natalie Thomas, Caroline Gurvich, Jayashri Kulkarni

      Pages 79-91

      PDF

   4. Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known?

      • Patrícia Brito Rodrigues, Arilson Bernardo dos Santos Pereira Gomes, Lívia Moreira Genaro, Lívia Bitencourt Pascoal, Ana Paula Duarte de Souza, Raquel Franco Leal et al.

      Pages 93-106

      PDF

   5. SARS-CoV-2 Infection and the Kidneys: An Evolving Picture

      • Jaya A. George, Siyabonga Khoza

      Pages 107-118

      PDF

   6. Cutaneous Manifestations of COVID-19: Early Diagnosis and Prognostic Information

      • Beatriz Burger, Hosana Gomes Rodrigues

      Pages 119-127

      PDF

   7. How Do We Manage Breastfeeding During the COVID-19 Pandemic?

      • Behnaz Abiri, Paul C. Guest, Mohammadreza Vafa

      Pages 129-137

      PDF

   8. Deep Learning Analysis in Prediction of COVID-19 Infection Status Using Chest CT Scan Features

      • Asma Pourhoseingholi, Mohsen Vahedi, Samira Chaibakhsh, Mohamad Amin Pourhoseingholi, Amir Vahedian-Azimi, Paul C. Guest et al.

      Pages 139-147

      PDF

5. Treatments and Vaccines

   1. Front Matter

      Pages 149-149

      PDF

   2. Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review

      • Sarvin Radvar, Sepideh Karkon-shayan, Ali Motamed-Sanaye, Mohammadreza Majidi, Sakineh Hajebrahimi, Negar Taleschian-Tabrizi et al.

      Pages 151-160

      PDF

   3. COVID-19, Coenzyme Q10 and Selenium

      • I. R. Hargreaves, D. Mantle

      Pages 161-168

      PDF

   4. Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19)

      • Victor B. Hsue, Kyohei Itamura, Arthur W. Wu, Elisa A. Illing, Kevin J. Sokoloski, Bree A. Weaver et al.

      Pages 169-189

      PDF

   5. Cinnamon: A Promising Natural Product Against COVID-19

      • Azadeh Zareie, Davood Soleimani, Gholamreza Askari, Tannaz Jamialahmadi, Paul C. Guest, Mohammad Bagherniya et al.

      Pages 191-195

      PDF

The novel coronavirus 2019 (COVID-19) has caused a serious global pandemic in just one year. Nearly every country and territory in the world has been affected by the virus. The virulence and infection rate of the virus are profound, and has required extreme social distancing measures across the globe in order to prevent overwhelming the healthcare services and hospitals. COVID-19 appears to have the greatest effects on elderly individuals and those who have co-morbid diseases, such as diabetes and obesity. As the cases and death rate remain high, there are justified fears of this virus remaining for several months or years to come. To address this, a rapid and unprecedented worldwide mobilization effort has begun to identify effective treatments and develop vaccines. As these begin to be deployed and administered across the globe, many now feel the virus will be brought under control and lives will eventually return to normal.

This new volume will increase readers’understanding of the ongoing COVID-19 pandemic through a series of chapters that address these concerns. Leading experts will discuss new treatment approaches, vaccine development, mental health aspects of the pandemic, and convey the results of survey studies. The book will be an excellent resource for researchers studying virology, metabolic diseases, respiratory disorders, and clinical scientists, physicians, drug companies, and healthcare services and workers.

 

 

• vaccine development
• novel coronavirus
• co-morbidities
• SARS
• MERS
• therapeutics
• interferon treatment
• antiviral medications
• steroids
• convalescent plasma
• coagulopathies
• lifestyle factors
• physical fitness
• pregnancy
• cytokine
• obesity
• mental health
• diabetes
• disease outcome

• Charlesworth House, Debden, UK

  Paul C. Guest

Dr. Paul C. Guest, Ph.D, is a scientific researcher/writer with 38 years of experience in the fields of metabolic and neurological disorders. This includes experience in both academia and the pharmaceutical industry with the majority of time spent at the University of Cambridge and Merck Sharp & Dohme in the United Kingdom. He has also been affiliated with the University of Campinas in Sao Paulo Brazil since 2015, still focused on advancing the field of biomarkers for neurological disorders such as schizophrenia and age-related diseases such as diabetes, cancer, cardiovascular disorders, sarcopenia and Alzheimer’s disease. 

Policies and ethics